Novozymes Biopharma secures business innovation award
21 July 2011 | By The Scott Partnership
Novozymes Biopharma, received the 2011 NEP Business Award...
List view / Grid view
News
FDA Advisory Committee recommends approval of Remicade®
21 July 2011 | By
The Gastrointestinal Drugs Advisory Committee (GIDAC) of the U.S. FDA recommended the approval of REMICADE® (infliximab)...
Pfizer to acquire Icagen
20 July 2011 | By Pfizer
Pfizer Inc. and Icagen, Inc. announced that they have entered into a definitive merger agreement....
FDA approves new medicine BRILINTA (ticagrelor) for use in the US
20 July 2011 | By AstraZeneca
The US FDA has approved BRILINTA (ticagrelor) tablets...
Merck and Roche expand agreement in fight against chronic hepatitis C
20 July 2011 | By Merck
Merck has signed a new non-exclusive agreement with Roche...
FDA Advisory Committee makes recommendation on investigational compound dapagliflozin
20 July 2011 | By AstraZeneca
FDA Endocrinologic and Metabolic Drugs Advisory Committee meeting outcome...
Idera Reports Clinical Hold on Proposed Phase 2 Clinical Trial of IMO-3100
20 July 2011 | By Idera Pharmaceuticals
Idera Pharmaceuticals announced the receipt of a verbal communication from the U.S. FDA that a proposed Phase 2 protocol...
Thermo Fisher Scientific wins R&D 100 award with UV-Vis Spectrophotometer
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its Evolution 200 series of next-generation UV-Visible spectrophotometers featuring INSIGHT and CUE (Customized User Environment) software has been named one of the most technologically significant products of the past 12 months by R&D Magazine.
Optibrium Launches New Version of Free StarVue App
19 July 2011 | By The Scott Partnership
Optibrium launches a new version of StarVue...
Sigma® Life Science Launches CompoZr® Targeted Integration Kit – mRosa26 for the Mouse Genome
19 July 2011 | By kdm communications limited
Sigma Life Science, announced the launch of CompoZr Targeted Integration Kit – mRosa26...
Edurant™ 96-Week Phase 3 safety and efficacy data presented
19 July 2011 | By Janssen Therapeutics
Janssen Therapeutics, presented 96-week findings from two pivotal Phase 3 clinical trials...
Millennium submits supplemental new drug application with FDA
19 July 2011 | By Takeda Pharmaceutical Company Limited
Millennium announced the submission of a supplemental New Drug Application (sNDA) with the U.S. FDA for VELCADE® (bortezomib)...
Lilly presents follow-up data on semagacestat to assist future Alzheimer’s disease research
19 July 2011 | By Eli Lilly and Company
Data presented from the first of two Phase III trials of semagacestat...
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
19 July 2011 | By Roche
Roche has signed an agreement to acquire 100% of mtm laboratories AG (mtm)...
Florbetapir “Imaging to Autopsy” study awarded Alzheimer’s Association’s 2011 de Leon Prize in Neuroimaging
18 July 2011 | By Eli Lilly and Company
Winner of the 2011 de Leon Prize in Neuroimaging...
